Skip to content

Efficacy of Homoeopathic Potentized Medicine Carcinosinum in reduction of Serum Antibody levels in Hashimoto’s Thyroiditis

Efficacy of Homoeopathic Potentized Medicine Carcinosinum in Reduction of Serum Antibody levels of Hashimotos Thyroiditis; A Double Blind Randomized Placebo Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059761
Enrollment
72
Registered
2023-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E063- Autoimmune thyroiditis

Interventions

Intervention1: Homoeopathic Potentized Medicine Carcinosinum: Homoeopathic Potentized Medicine Carcinosinum: In this study, Carcinosinum will be procured from a GMP certified Pharmacy at a specific di

Sponsors

Dr Rahitha K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients from 18-60 years of age, All Genders. 2. Patients with Anti TPO above 34 IU/mL and/or Anti Thyroglobulin above 64 IU/mL. 3. Patients under Conventional Oral Hormone Replacement Therapy.

Exclusion criteria

Exclusion criteria: 1. Cases with Malignant thyroid tumors. 2. Patients with other severe systemic illness like uncontrolled diabetes, Malignant Hypertension, Severe cardiac diseases, Malignancies. 3. Immuno-compromised patients- HIV/AIDS, TB. 4. Pregnant women and Lactating mothers.

Design outcomes

Primary

MeasureTime frame
Changes in Serum Antibody levels (once in 3 months).Timepoint: once in 3 months for 6 months

Secondary

MeasureTime frame
Changes in Quality of life using WHO-QOL BREF score (once in 3months) and changes in serum TSH levels (once in 3months).Timepoint: once in 3months for 6 months

Countries

India

Contacts

Public ContactDr R S Krishneswari

National Homoeopathy Research Institute in Mental Health

krishneswarirs@gmail.com9445646864

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026